Salipro Biotech and Boehringer Ingelheim Strike Research and License Deal to Boost…
Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets,…
Trending
- Salipro Biotech and Boehringer Ingelheim Strike Research and License Deal to Boost Pipeline Programs
- AstraZeneca Signs License Deal with Alteogen for Subcutaneous Oncology Formulations
- AstraZeneca to Acquire EsoBiotec to Boost Cell Therapy Goals
- Bristol Myers Squibb Gains EU Approval to Expand Breyanzi CAR T Therapy for Follicular Lymphoma
- Latigo Biotherapeutics Secures $150 Million in Series B Funding to Propel Development of Non-Opioid Pain Treatments
- Azurity Pharmaceuticals Acquires Covis Pharma
- Zealand Pharma and Roche Partner to Co-Develop Petrelintide for Overweight and Obesity Treatment
- Merck Reports Positive Phase 3 Data for Doravirine/Islatravir (DOR/ISL) in HIV-1 Treatment
- Vivace Therapeutics Secures $35 Million in Series D to Advance First-in-Class Cancer Drug
- Emergent BioSolutions and Rocketvax Announce Investment Agreement to Advance Next-Generation Product Candidates
Top Headlines
AstraZeneca Signs License Deal with Alteogen for Subcutaneous Oncology Formulations
AstraZeneca and Alteogen Inc. have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase…
AstraZeneca to Acquire EsoBiotec to Boost Cell Therapy Goals
AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in…
Bristol Myers Squibb Gains EU Approval to Expand Breyanzi CAR T Therapy for Follicular…
Bristol Myers Squibb announced that the European Commission (EC) has granted approval to Breyanzi (lisocabtagene…
Latigo Biotherapeutics Secures $150 Million in Series B Funding to Propel Development of…
Latigo Biotherapeutics ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid pain…
Azurity Pharmaceuticals Acquires Covis Pharma
Azurity Pharmaceuticals announced the successful completion of its acquisition of Covis Group S.à r.l. (“Covis”)…
Featured Event
Clinical Trials
Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024
Navidea Biopharmaceuticals, Inc. a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced…
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
Neumora Therapeutics, Inc. announced that the Phase 1 trial of NMRA-266 has been placed on clinical hold by the U.S. Food and Drug Administration…
Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbuphine ER) for the…
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to…
Immunocore Holdings plc, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically…
PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic…
PepGen Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the…
Johnson & Johnson reports positive topline results for nipocalimab from a Phase 3 pivotal study…
Johnson & Johnson announced topline results from the pivotal Phase 3 VIVACITY study of nipocalimab in adults living with generalized myasthenia…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Gensaic Partners with Novo Nordisk to Develop Next-Gen Precision Therapies
Gensaic, Inc. (Gensaic), a biotechnology company that combines AI-powered protein design with biological insights…
Merck Launches First Software for Complete Data Traceability in Microbial QC
Merck, a leading science and technology company, has launched its M-Trace Software & Mobile App, a…
Drug Research
AbbVie and Gubra Strike License Deal to Develop Amylin Analog for Obesity
AbbVie and Gubra A/S, a company specializing in preclinical contract research services and peptide-based drug…
Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop…
Biogen Inc. and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders…
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License…
AbbVie and Gilgamesh Pharmaceuticals announced a collaboration and option-to-license agreement to develop…
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific…
AbbVie Inc. and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and…
FDA Grants Orphan Drug Designation to NeoImmuneTech’s NT-I7 for the Treatment of…
NeoImmuneTech, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation…
Manufacturing
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing…
Charles River Laboratories International, Inc. and Captain T Cell, a spinoff from the renowned Max Delbrück Center…
Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for…
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization…
Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of…
Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that…
Astraveus awarded €10.4 million grant by the French government as part of France 2030…
Astraveus SAS, the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT)…
Samsung Biologics and Kurma Partners announce strategic partnership for development and…
Samsung Biologics and Kurma Partners announced a strategic partnership for the development and manufacturing of…
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of…
Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind…
MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is the first CTDMO…
Astellas to Invest more than €330 Million in a New State-of-the-Art Facility in Tralee,…
Astellas Pharma Inc. announced its intention to submit a planning application to build a new state-of-the-art…
Diseases
SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation…
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to…
Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ (metronidazole) Oral…
Kesin Pharma Corporation, a pharmaceutical company focused on innovative Specialty brands and Unit Dose…
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss…
Regeneron Pharmaceuticals, Inc. and Decibel Therapeutics, Inc., a clinical-stage biotechnology company dedicated to…
Ionis enters collaboration to advance next generation program targeting Lp(a) for…
Ionis Pharmaceuticals, Inc. announced that it has entered a collaboration and license agreement with Novartis for…
FDA Approves Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of…
Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration…
RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First…
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that its partner, Gaelan Medical LLC, a…
